Abiomed Seeks Inter Parte Review and Declaratory Judgment of Non-Infringement of Maquet Cardiovascular’s Blood Pump Patents

On March 11, 2017, Abiomed, Inc., Abiomed R&D, Inc., and Abiomed Europe GmbH (collectively, “Abiomed”) petitioned Patent Trial and Appeal Board for inter parte review of the three blood pump patents owned by Maquet Cardiovascular LLC (“Maquet”).  In a separate proceeding, Abiomed has filed a declaratory judgment action against Maquet for non-infringement of the same patents in the District of Massachusetts (Case No. 1:16-cv-10914).

The patents-at-issue are U.S. Patent Nos. 7,022,100, 8,888,728, 9,327,068, each entitled, “Guidable Intravascular Blood Pump and Related Methods.”  The case numbers are IPR2017-01025, IPR2017-01026, IPR2017-01027, IPR2017-01028, and IPR2017-01029.

By: Chika Seidel